0001842612-24-000003.txt : 20240110
0001842612-24-000003.hdr.sgml : 20240110
20240110163827
ACCESSION NUMBER: 0001842612-24-000003
CONFORMED SUBMISSION TYPE: 144/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240110
DATE AS OF CHANGE: 20240110
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC.
CENTRAL INDEX KEY: 0001401667
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 770683487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-35703
FILM NUMBER: 24527020
BUSINESS ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
BUSINESS PHONE: (424) 248-6500
MAIL ADDRESS:
STREET 1: 10880 WILSHIRE BLVD.
STREET 2: SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP
DATE OF NAME CHANGE: 20070601
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wong Alvin F
CENTRAL INDEX KEY: 0001868855
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144/A
MAIL ADDRESS:
STREET 1: C/O PUMA BIOTECHNOLOGY, INC.
STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150
CITY: LOS ANGELES
STATE: CA
ZIP: 90024
144/A
1
primary_doc.xml
144/A
0002006196-24-000004
0001868855
XXXXXXXX
LIVE
0001401667
PUMA BIOTECHNOLOGY, INC.
001-35703
10880 WILSHIRE BLVD.
SUITE 2150
LOS ANGELES
CA
90024
(424) 248-6500
Wong Alvin F
Officer
Common Stock
Muriel Siebert & Co., Inc.
4141 NE 2nd Avenue, Suite 201
Miami
FL
33137
7733
34991.83
47571332
01/03/2024
NASDAQGS
Common Stock
03/03/2022
Restricted Stock Unit Grant
PUMA BIOTECHNOLOGY, INC.
N
44882
03/03/2022
Compensation for Services Rendered
Common Stock
02/10/2023
Restricted Stock Unit Grant
PUMA BIOTECHNOLOGY, INC.
N
58601
02/10/2023
Compensation for Services Rendered
N
Muriel Siebert & Co., Inc.
4141 NE 2nd Avenue, Suite 201
Miami
FL
33137
Common Stock
12/04/2023
280
1053.02
The Form 144 filed on January 3, 2024 is hereby amended to include the sale of 280 shares in Table II.
01/10/2024
12/15/2020
/s/ Gordon Esplin, Attorney-in-Fact for Alvin F. Wong